Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CELLPRO CEPRATE SC BONE MARROW STEM CELL CONCENTRATION SYSTEM GAINS FDA APPROVAL DEC. 6; FIRM LAUNCHES SYSTEM AT AMERICAN SOCIETY OF HEMATOLOGY

This article was originally published in The Gray Sheet

Executive Summary

CellPro has begun shipping its Ceprate SC stem cell concentration system at a price of $24,985 following FDA approval Dec. 6 of a premarket approval application for the device. The approval is FDA's first for a system to purify stem cells for bone marrow transplantation.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT007245

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel